UPDATE : Friday, September 20, 2019
상단여백
Kolmar apologizes for playing controversial YouTube clip by Lee Han-soo 2019-08-09 16:48
Diabetes drug Jardiance pressures heart failure treatment Entresto by Kim Yun-mi 2019-08-09 15:44
Only 1% of severe epilepsy patients get surgery in Korea by Song Soo-youn 2019-08-09 13:48
AstraZeneca’s Lynparza show positive results for prostate cancer in P3 trial by Lee Han-soo 2019-08-08 16:48
Mammotome procedure recognized as new medical technology by Choi Gwang-seok 2019-08-08 16:02
라인
SNUH resumes operation of UAE hospital by Lee Han-soo 2019-08-08 15:59
Drug regulator to enhance clinical trial management by 2023 by Lee Hye-seon 2019-08-08 14:55
Preoperative embolization proves effective against non-hypervascular metastatic spine tumors by Lee Han-soo 2019-08-08 14:54
‘CPhI Korea thriving on local firms’ zeal for drug export’ by Jeong Sae-im 2019-08-08 14:54
Hanmi’s US partner unveils P3 data on oral anticancer drug by Lee Han-soo 2019-08-08 14:53
라인
'Daewoong risk' could put a damper on AbbVie-Allergan mega-merger by Lee Han-soo 2019-08-07 16:22
Lilly’s anticancer combo drug nears getting insurance benefit by Kim Yun-mi 2019-08-07 15:44
Over 5,700 patients received Allergan’s breast implants linked to rare cancer by Song Soo-youn 2019-08-07 15:43
[Reporter’s Notebook] SillaJen should be ashamed of itself by Jeong Sae-im 2019-08-07 13:59
Lilly reports improved survival for Verzenio in P3 trial by Lee Han-soo 2019-08-07 12:06
라인
ISU Abxis to unveil p1 results for anticancer treatment in Europe by Lee Han-soo 2019-08-07 12:03
Crystal Genomics signs accord with CRO firm by Lee Han-soo 2019-08-06 17:20
Myongji Hospital opens sports medicine center by Lee Han-soo 2019-08-06 16:54
Japanese firms fear boycott may hurt prescription drug sales by Kim Yun-mi 2019-08-06 15:44
Sillajen cites salvation therapy as reason for trial suspension advice by Lee Han-soo 2019-08-06 15:43
여백
여백
여백
Back to Top